National Forum for State and Territorial Chief Executives (National Forum) Program Cooperative Agreement, 17658 [2011-7444]
Download as PDF
<![CDATA[
17658
Federal Register / Vol. 76, No. 61 / Wednesday, March 30, 2011 / Notices
III. What are the topics we intend to
address at the public workshop?
We intend to discuss a large number
of issues at the workshop, including, but
not limited to the following:
• Establishment of the MDEpiNet
infrastructure,
• Gaps and challenges in medical
device outcomes and epidemiologic
studies,
• Opportunities for medical device
epidemiologic research and
partnerships between the Center for
Devices and Radiological Health and
academia.
IV. Where can I find out more about
this public workshop?
Background information on the public
workshop, registration information, the
agenda, information about lodging, and
other relevant information will be
posted, as it becomes available, on the
Internet at https://fda-ws.s-3.net/
EpiNetWSApr11/.
Dated: March 25, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011–7434 Filed 3–29–11; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
National Forum for State and Territorial
Chief Executives (National Forum)
Program Cooperative Agreement
Health Resources and Services
Administration (HRSA), HHS.
ACTION: Notice of Non-competitive OneYear Extension With Funds for the
National Forum for State and Territorial
Chief Executives (National Forum)
Program Cooperative Agreement.
Original Period of Support: April 1,
2008, to March 31, 2011.
Amount of Supplement Award:
$160,000.
Authority: Sections 241 and 301 of the
Public Health Service Act, as amended
(42 U.S.C. 238J and 241 respectively).
CFDA Number: 93.224.
Justification for the Exception to
Competition: The National Forum
cooperative agreement provides a
unique vehicle for HRSA to collaborate
with the Nation’s governors on their
shared priorities, and provides
opportunities through which governors
can build on lessons others states have
learned in addressing similar health
policy challenges. A 1-year extension
with funds will allow the National
Forum to facilitate ongoing
communication on emerging strategies
addressing common priorities, public
health policy, and governance issues
affecting States and Territories thereby
allowing HRSA to reevaluate the focus
and implementation of this Program
prior to the FY 2012 competition for the
next 3-year project period. Further
funding beyond March 31, 2012, will be
competitively awarded in FY 2012.
FOR FURTHER INFORMATION CONTACT:
Mark Pincus, Director, Office of Policy
Analysis, HRSA, via e-mail:
mpincus@hrsa.gov or via telephone:
301–443–5911.
Dated: March 23, 2011.
Mary K. Wakefield,
Administrator.
[FR Doc. 2011–7444 Filed 3–29–11; 8:45 am]
BILLING CODE 4165–15–P
AGENCY:
HRSA will be providing a
one-year extension with funds in the
amount authorized in fiscal year (FY)
2010 to support activities that focus on
cross-cutting publicly-funded health
program integration and health access
issues identified by the State and
Territory governors and their senior
health policy advisors, including
addressing the needs of uninsured,
underinsured and special needs
populations, oral health, border health
and health information technology as
well as HRSA’s overall strategic goals.
SUPPLEMENTARY INFORMATION:
Cooperative Agreement Recipient of
Record: National Governors Association
Center for Best Practices (NGA),
Washington, DC.
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
14:59 Mar 29, 2011
Jkt 223001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK Central
Repositories Non-Renewable Sample Access
(X01)-Hepatitis C.
Date: April 26, 2011.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call)
Contact Person: Najma Begum, PhD,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 749, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8894,
begumn@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: March 24, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–7500 Filed 3–29–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; ‘‘Mouse Resource’’.
Date: April 20, 2011.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817,
(Telephone Conference Call)
Contact Person: Gregory P. Jarosik, PhD,
Scientific Review Administrator, Scientific
E:\FR\FM\30MRN1.SGM
30MRN1
]]>Agencies
[Federal Register Volume 76, Number 61 (Wednesday, March 30, 2011)]
[Notices]
[Page 17658]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-7444]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
National Forum for State and Territorial Chief Executives
(National Forum) Program Cooperative Agreement
AGENCY: Health Resources and Services Administration (HRSA), HHS.
ACTION: Notice of Non-competitive One-Year Extension With Funds for the
National Forum for State and Territorial Chief Executives (National
Forum) Program Cooperative Agreement.
-----------------------------------------------------------------------
SUMMARY: HRSA will be providing a one-year extension with funds in the
amount authorized in fiscal year (FY) 2010 to support activities that
focus on cross-cutting publicly-funded health program integration and
health access issues identified by the State and Territory governors
and their senior health policy advisors, including addressing the needs
of uninsured, underinsured and special needs populations, oral health,
border health and health information technology as well as HRSA's
overall strategic goals.
SUPPLEMENTARY INFORMATION:
Cooperative Agreement Recipient of Record: National Governors
Association Center for Best Practices (NGA), Washington, DC.
Original Period of Support: April 1, 2008, to March 31, 2011.
Amount of Supplement Award: $160,000.
Authority: Sections 241 and 301 of the Public Health Service Act,
as amended (42 U.S.C. 238J and 241 respectively).
CFDA Number: 93.224.
Justification for the Exception to Competition: The National Forum
cooperative agreement provides a unique vehicle for HRSA to collaborate
with the Nation's governors on their shared priorities, and provides
opportunities through which governors can build on lessons others
states have learned in addressing similar health policy challenges. A
1-year extension with funds will allow the National Forum to facilitate
ongoing communication on emerging strategies addressing common
priorities, public health policy, and governance issues affecting
States and Territories thereby allowing HRSA to reevaluate the focus
and implementation of this Program prior to the FY 2012 competition for
the next 3-year project period. Further funding beyond March 31, 2012,
will be competitively awarded in FY 2012.
FOR FURTHER INFORMATION CONTACT: Mark Pincus, Director, Office of
Policy Analysis, HRSA, via e-mail: mpincus@hrsa.gov or via telephone:
301-443-5911.
Dated: March 23, 2011.
Mary K. Wakefield,
Administrator.
[FR Doc. 2011-7444 Filed 3-29-11; 8:45 am]
BILLING CODE 4165-15-P
